Zou Yurui, Zhao Yunxiang, Yu Jia, Luo Xue, Han Jiangbo, Ye Zhijia, Li Jintao, Lin Hui
Institute of Tropical Medicine, Third Military Medical University, Chongqing, China.
Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing, China.
J Cosmet Dermatol. 2016 Dec;15(4):374-382. doi: 10.1111/jocd.12236. Epub 2016 Jun 30.
Surgical excision (SE) is a first-line treatment for basal cell carcinoma (BCC). Topical photodynamic therapy (PDT) has also been used and has cosmetic advantages over surgery. The latest European guidelines for topical PDT recommended that it be used to treat nodular basal cell carcinoma (nBCC) but a consensus has not been reached. Our study was to evaluate the efficacy of PDT versus SE for the treatment for nBCC by a meta-analysis.
We searched PubMed, EMBASE, the Cochrane Library, CKNI, VIP, and relevant references up to October 2014 including randomized controlled trials (RCTs) that compared PDT with SE for treatment of nBCC patients. A meta-analysis was conducted by using the Cochrane Collaboration's revman 5.0 software.
We selected five studies that covered 596 of pathologically confirmed nBCC. We compared complete response rate (RR) of PDT and SE at 3 months and 1, 2, 3, 4, and 5 years. We found that the RR was 0.95 (0.90, 1.00), 0.89 (0.80, 0.99), 0.83 (0.69, 1.00), 0.73 (0.63, 0.85), 0.84 (0.65, 1.08), and 0.79 (0.61, 1.03), respectively, for those time points, the cumulative probability of recurrence for the time points post-treatment, with an estimate at RR 5.28 (1.85, 15.12), 6.48 (2.46, 17.09), 9.67 (3.02, 30.99), 7.73 (2.81, 21.28), and 8.25 (3.01-22.62), respectively.
We observed no significant differences between PDT and SE for the complete RR, but there was an increased cumulative probability of recurrence. More large-scale RCTs are required to verify our findings.
手术切除(SE)是基底细胞癌(BCC)的一线治疗方法。局部光动力疗法(PDT)也已被使用,且与手术相比具有美容优势。欧洲最新的局部光动力疗法指南推荐其用于治疗结节性基底细胞癌(nBCC),但尚未达成共识。我们的研究旨在通过荟萃分析评估PDT与SE治疗nBCC的疗效。
我们检索了截至2014年10月的PubMed、EMBASE、Cochrane图书馆、中国知网、维普资讯及相关参考文献,纳入比较PDT与SE治疗nBCC患者的随机对照试验(RCT)。使用Cochrane协作网的revman 5.0软件进行荟萃分析。
我们选择了五项研究,共涵盖596例经病理证实的nBCC。我们比较了PDT和SE在3个月及1、2、3、4和5年时的完全缓解率(RR)。我们发现,在这些时间点,RR分别为0.95(0.90,1.00)、0.89(0.80,0.99)、0.83(0.69,1.00)、0.73(0.63,0.85)、0.84(0.65,1.08)和0.79(0.61,1.03),治疗后各时间点的复发累积概率估计RR分别为5.28(1.85,15.12)、6.48(2.46,17.09)、9.67(3.02,30.99)、7.73(2.81,21.28)和8.25(3.01 - 22.62)。
我们观察到PDT和SE在完全缓解率方面无显著差异,但复发累积概率有所增加。需要更多大规模的RCT来验证我们的发现。